Our results suggest that cardiomyocytes can compensate for the lack of dystrophin in the healthy heart (10 kPa), but not the stiff, fibrotic heart (35 kPa), which could explain why DMD patients become increasingly susceptible to arrhythmia and heart failure as they age. This evidence concerns the gene DMD and cardiac arrhythmia.